The study showed that patients admitted to academic medical centers that care for more patients with severe sepsis have significantly lower mortality
rates than patients cared for at academic medical centers with lower volumes of sepsis patients.
Patients who had sentinel node biopsies had significantly greater 10 - year disease - free survival
rates than patients who underwent nodal observation.
The study authors concluded that patients at NSQIP hospitals seemed to have lower inpatient mortality
rates than patients» hospitals in the NIS database.
Some of the potential complications of surgical mesh include pain, infection, bleeding, organ perforation urinary problems or vaginal mesh erosion at higher
rates than patients who elect for traditional surgery.
Not exact matches
Adds Henry: «Across the more
than 3,500 clients who hire us (and our renewal
rates are typically 95 % and higher), we deliver the savings we promise by providing solutions that drive out pharmacy waste, control costs, and improve
patient outcomes.»
Black Medicare
patients are being readmitted to hospitals at a much higher
rate than white
patients, according to a recent study.
Controlling for the share of a hospital's admissions of low - income
patients (with Medicaid insurance) or its share of surgical admissions all added more information
than Yelp
ratings alone.
Patients who enrolled in BCBS individual plans in 2014 and 2015 have higher
rates of certain diseases — depression, hypertension, diabetes, coronary artery disease, HIV and hepatitis C —
than individuals enrolled in coverage prior to ACA implementation.
These risks and uncertainties include: Gilead's ability to achieve its anticipated full year 2018 financial results; Gilead's ability to sustain growth in revenues for its antiviral and other programs; the risk that private and public payers may be reluctant to provide, or continue to provide, coverage or reimbursement for new products, including Vosevi, Yescarta, Epclusa, Harvoni, Genvoya, Odefsey, Descovy, Biktarvy and Vemlidy ®; austerity measures in European countries that may increase the amount of discount required on Gilead's products; an increase in discounts, chargebacks and rebates due to ongoing contracts and future negotiations with commercial and government payers; a larger
than anticipated shift in payer mix to more highly discounted payer segments and geographic regions and decreases in treatment duration; availability of funding for state AIDS Drug Assistance Programs (ADAPs); continued fluctuations in ADAP purchases driven by federal and state grant cycles which may not mirror
patient demand and may cause fluctuations in Gilead's earnings; market share and price erosion caused by the introduction of generic versions of Viread and Truvada, an uncertain global macroeconomic environment; and potential amendments to the Affordable Care Act or other government action that could have the effect of lowering prices or reducing the number of insured
patients; the possibility of unfavorable results from clinical trials involving investigational compounds; Gilead's ability to initiate clinical trials in its currently anticipated timeframes; the levels of inventory held by wholesalers and retailers which may cause fluctuations in Gilead's earnings; Kite's ability to develop and commercialize cell therapies utilizing the zinc finger nuclease technology platform and realize the benefits of the Sangamo partnership; Gilead's ability to submit new drug applications for new product candidates in the timelines currently anticipated; Gilead's ability to receive regulatory approvals in a timely manner or at all, for new and current products, including Biktarvy; Gilead's ability to successfully commercialize its products, including Biktarvy; the risk that physicians and
patients may not see advantages of these products over other therapies and may therefore be reluctant to prescribe the products; Gilead's ability to successfully develop its hematology / oncology and inflammation / respiratory programs; safety and efficacy data from clinical studies may not warrant further development of Gilead's product candidates, including GS - 9620 and Yescarta in combination with Pfizer's utomilumab; Gilead's ability to pay dividends or complete its share repurchase program due to changes in its stock price, corporate or other market conditions; fluctuations in the foreign exchange
rate of the U.S. dollar that may cause an unfavorable foreign currency exchange impact on Gilead's future revenues and pre-tax earnings; and other risks identified from time to time in Gilead's reports filed with the U.S. Securities and Exchange Commission (the SEC).
Despite the Federal Reserve removing the «
patient» language from its statement, investors feel we are further from a
rate hike
than previously anticipated.
Researchers from Aston Medical School in Birmingham looked at more
than 900,000
patients with high blood pressure, high cholesterol and type 2 diabetes and found marriage led to higher survival
rates.
The authors asked hospitalized
patients to
rate conditions — which they were not then experiencing — on a sliding scale, ranging from «worse
than death, neither better nor worse
than death, a little better
than death, somewhat better
than death, or much better
than death.»
Patients displayed considerable heterogeneity in their ratings of health states relative to death... but significant percentages of patients rated each evaluated state of serious functional debility as equal to or worse tha
Patients displayed considerable heterogeneity in their
ratings of health states relative to death... but significant percentages of
patients rated each evaluated state of serious functional debility as equal to or worse tha
patients rated each evaluated state of serious functional debility as equal to or worse
than death.
He must not be sold.He's also better
than a lot of Chelsea youngsters.That's not enough basis for him to be sold.At top form he's better
than Pedro, Moses and Willain.These are players whose main strength is dribbling and he tops them there no doubt.I remember him in one season having the highest dribble success
rate percentage in the EPL.All he needs is to develop a level of consistency.A lot of their youngsters have potential but most won't be good as the Ox.The Ox himself has not reached full potential yet.He hasn't developed a certain level of consistency.Him also being a squad player is because of those above him.Those above him are all quality players.This won't be smart business at all.He's just going to destroy himself in another club and after being
patient with him we are now deciding to sell him?
It would be a shame to lose Jack, who I
rate higher
than Ramsey, after we were so
patient during his many injuries, if he now finally has a full season playing up to his potential.
A study in 2011 looking at more
than 645 ACL surgeries found that in
patients between the ages of 10 ««19, allograft tissue had a four times higher failure
rate than using your own tissue.
@ larryking listen jock wenger could never coach anyother club because no big club would go six season without a trophy there is no way wenger could go to madrid and go two season without a trophy no way in hell he would be fired in no time bmunich fired klinsman less
than half season look at the real madrid coach grave yard pelligrinie made 95 + points last season that amount would win the league in almost any country yet he got fired i can go on if fergi goes two seasons without a trophy am sure he gone i love arsenal but football is about winning trophies wenger has hypnotize you i do nt care arsenal have gone five years without a trophy and six witout the league not even a carling cup or fa cup and loosing all our best players all for money all this talk about wenger and his youth policies i can count on both hands all the players that came through arsenal youth system that went on to be world beaters look at the current crop walcott nasri diaby denilson bedtner clichy none of these are world class they have improve minimal @ arsenal compare that to barca their youths pedro and co are world beaters event the great vanpercy who we
rate he would never leave arsenal because all that chance wenger gives him he would» t get at other big clubs this does not make sense we buy young players they take ages to develop most do nt» t then we sell them or they leave because they want to win things that how you grow pretty soon that top four will become very hard to stay in if we get out of that then what i wish all you wenger fans luck am all out of
patients with him last chance this year................
If properly trained midwives exclude higher risk
patients in advance, then why is their death
rate acceptable only in a study that has much stricter criteria for inclusion
than real life?
Analyzing medical death
rate data over an eight - year period, John Hopkins
patient safety experts have calculated that more
than 250,000 deaths per year are due to medical error in the United States.
Sometimes there are good reasons, but sometimes the reasons are related to insurance
rates, or demands on doctors» time (some hospitals require an OB attending a VBAC to be in house the entire time the VBAC is laboring, and few doctors want to do this) rather
than the most medically appropriate choice or
patient safety.
There were no differences between groups in parity, incidence of diabetes, operative delivery, or third - degree compared with fourth - degree lacerations.By 2 weeks postpartum,
patients who received prophylactic antibiotics at the time of third - or fourth - degree laceration repair had a lower
rate of perineal wound complications
than patients who received placebo.ClinicalTrials.gov, www.clincaltrials.gov, NCT00186082.I.
So even when homebirth midwives stick to low risk
patients, homebirth has a death
rate 320 % higher
than comparable risk hospital birth.
> So even when homebirth midwives stick to loss risk
patients, homebirth has a death
rate 320 % higher
than comparable risk hospital birth.
In any
patient, the Cesarean section
rate for twins is MUCH higher
than for singletons, secondary to increased
rates of need for induction and abnormal presentation.
It has made clear it does not intend to ban NHS organisations from using 084 numbers, but only ensure
patients do not pay more
than their local
rate.
In a statement the Department of Health said: «The ban on the use of numbers charging
patients a premium
rate to call NHS services will allow a marketplace to evolve where 084 numbers compete alongside 01, 02 and 03 numbers, but where
patients will pay no more
than the cost of a local call.
Sara Hiom, Cancer Research UK's director of health information, said: «Survival
rates for breast cancer have been improving for more
than 20 years - eight out of ten
patients now survive more
than five years.
As a result, waiting times are higher in Wales, cancer
patients are being denied life - prolonging drugs which they would have access to if they lived in England, and spending on medicines has «decreased at a faster
rate than elsewhere in the UK», according to the Office for Health Economics.
If the initial cap is set high enough, and allows for a
rate of inflation based on actual medical costs (which is higher
than the average
rate of inflation), New York could cover health care for Medicaid
patients who obtained coverage under Obamacare.
At an early stage of development, the miniature organs grown from autistic
patients» stem cells also showed faster cell division
rates than those grown from the cells of non-autistic relatives.
The facts were clear: in diabetic
patients, the
rate of 2 - aminoadipase was lower
than in the rest.
«Our research indicates that insertion of cervical pessary at around 22 weeks in both randomly selected women pregnant with twins and in
patients with a short cervix of less
than 25 millimeters does not reduce the
rate of spontaneous early preterm birth, perinatal death, adverse neonatal outcome, or need for neonatal therapy.»
«Both estimates are higher
than published
rates for the general U.S. population, suggesting that special attention should be paid to these conditions among bariatric
patients,» the researchers write.
«
Patients with eczema have much higher rates of asthma than non-eczema patients,» Silverbe
Patients with eczema have much higher
rates of asthma
than non-eczema
patients,» Silverbe
patients,» Silverberg said.
In addition, some
patient groups and members of Congress have recently asked why AIDS receives disproportionately far more
than diseases with higher death
rates, such as heart disease and Alzheimer's.
Estimates suggest that more
than 230 million
patients undergo surgery worldwide each year, with reported mortality
rates between 1 percent and 4 percent.
While there have been improvements in the current standard treatments,
patients with glioblastoma (GBM), the most common and aggressive form of brain tumor, still suffer from a median survival
rate of only 14.6 months and 5 - year overall survival
rates of less
than 10 %.
«The increased death
rate is cause for concern, because the prognosis for this tumour is bleak, with less
than five percent of pancreatic cancer
patients surviving for five years after diagnosis.
Immunotherapy with a live bacterium combined with chemotherapy demonstrated more
than 90 % disease control and 59 % response
rate in
patients with malignant pleural mesothelioma (MPM), according to the results of a phase Ib trial presented today at the European Lung Cancer Conference (ELCC) 2016 in Geneva, Switzerland.1
The malignancy often remains undiagnosed until the cancer has spread, leaving
patients with a bleak prognosis and a five - year survival
rate of less
than 30 percent.
«We can offer more
patients reconstruction
than in the past, we have greater experience, but there is a tradeoff of possibly higher complication
rates.»
By taking the age of
patients» blood cells into account, the researchers» model, when tested in more
than 200 diabetic
patients, reduced the error
rate from one in three
patients with the standard blood test to an error
rate of one in 10.
In this study, rather
than studying one iPS cell line, the researchers derived and sequenced 10 iPS cell clones from each
patient tissue sample to get a better understanding of mitochondrial DNA mutation
rates.
Nonetheless, the overall success
rate in the high - risk population is over 88 percent, which the study authors consider high, although complications such as implant explantation and flap problems occur more frequently in the high - risk group
than in lower - risk
patients.
They didn't specifically examine rejection
rates, nor did they examine treatments other
than heart transplant or outcome among
patients without antibodies.
«African - American multiple myeloma
patients have higher incidence
rates and lower survival
rates than their Caucasian peers despite this being a relatively easy - to - treat cancer.
With a three - year survival
rate of 94.39 percent for all adult kidney recipients — above the 92.62 percent national average — UCSF has more
patients on the kidney transplant waiting list
than any other U.S. transplant center.
A study of over 224,000
patients and more
than 314,000 colonoscopies found that adenoma detection
rates closely tracked the future risk of colorectal cancer.
Although treatment has improved, the surgery
rate in
patients with ductal adenocarcinoma is around 30 percent and the five - year survival
rate is less
than 20 percent.
Studies show that PD - 1 inhibitors are effective for a larger proportion of melanoma
patients than ipilimumab alone — and, in combination with that drug, they achieve a two - year survival
rate of 80 percent.